Women's Health Weekly — 2026-08-24
Recent coverage highlights the ongoing disconnect in US healthcare policy, where Medicare’s proposed 2027 fee schedule increases maternity payments but remains silent on menopause care. Meanwhile, new research emphasizes the critical need to prioritize women in longevity studies and better integrate reproductive health with cardiovascular disease prevention.
Key Highlights
Medicare’s 2027 Fee Schedule Disparity CMS has proposed paying new labor-and-delivery codes 15% above its advisers' recommendation in the 2027 fee schedule. However, the 716-page document never mentions menopause, highlighting a persistent gap in federal reimbursement for midlife women's health. Public comments on this proposal close on September 14.
Reproductive Health and Heart Disease Link A recent report from ScienceAlert details how doctors are increasingly recognizing a link between women's reproductive health and heart disease. The article notes that the "Women's Heart Bus" in France offered combined cardiac and gynecological screenings to patients in precarious situations, illustrating the clinical necessity of treating these systems as interconnected rather than siloed.
Longevity Research Gap MedicalXpress published an analysis questioning why women, who live longer on average, face a greater burden of chronic disease later in life. The piece argues for prioritizing women in longevity research to understand the biological mechanisms behind this disparity.
Analysis
The juxtaposition of Medicare’s financial focus on childbirth while omitting menopause from its fee schedule underscores a systemic undervaluation of women's health post-reproductive years. As the ScienceAlert article points out, the clinical community is beginning to bridge the gap between gynecological and cardiovascular care, yet federal reimbursement policies have not caught up to this medical consensus. This lag may deter providers from offering comprehensive midlife screenings, potentially worsening long-term outcomes for women entering their most vulnerable cardiovascular years.
What to Watch
- September 14, 2026: The deadline for public comments on CMS’s proposed 2027 Medicare fee schedule, which currently lacks any mention of menopause-related services.
- Federal Reproductive Health Policy: Continued federal actions affecting medication abortion and Title IX enforcement are being monitored as state legislatures adjourn, with changes increasingly coming through court decisions and administrative actions.
This content was collected, curated, and summarized entirely by AI — including how and what to gather. It may contain inaccuracies. Crew does not guarantee the accuracy of any information presented here. Always verify facts on your own before acting on them. Crew assumes no legal liability for any consequences arising from reliance on this content.
Powered by
